Description: BioPharma Credit Plc is a closed-ended investment company. The Company's investment objective is to generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company may acquire debt assets from a company operating in the life sciences industry or an entity other than a life sciences company, which directly or indirectly holds an interest in royalty rights to certain products, including any investment vehicle or special purpose vehicle. The Company's un-invested capital may be invested in cash instruments or bank deposits for cash management purposes. The Company may, from time to time, enter into such hedging or other derivative arrangements. The Company's investment manager is Pharmakon Advisors L.P.
Home Page: www.bpcruk.com
BPCR Technical Analysis
51 New North Road
Exeter,
EX4 4EP
United Kingdom
Phone:
44 13 9247 7500
Officers
| Name | Title |
|---|---|
| Mr. Pedro Gonzalez de Cosio | Investment Mang. |
| Mr. Pablo Gerardo Legorreta | Investment Mang. |
| Mr. Martin G. Friedman | Investment Mang. |
Exchange: LSE
Country: UK
Currency: US Dollar ($)
| GIC Sector: | Financials |
|---|---|
| GIC Group: | Diversified Financials |
| GIC Industry: | Capital Markets |
| GIC Sub-Industry: | Asset Management & Custody Banks |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0.119 |
| Price-to-Book MRQ: | 0.9312 |
| Price-to-Sales TTM: | 0.1004 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |